Norwich, CT, United States of America

James T Downs

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of James T Downs

Introduction

James T Downs is an accomplished inventor based in Norwich, CT (US). He has made significant contributions to the field of biotechnology, particularly in the measurement of protein fragments in biological media. His work has implications for various medical and research applications.

Latest Patents

James T Downs holds a patent for "Assays for measurement of protein fragments in biological media." This invention provides novel antibodies and engineered versions thereof, along with methodologies for monitoring biological media for protein fragments. Notably, it focuses on collagen fragments resulting from collagenase cleavage of type II collagen. He has 1 patent to his name.

Career Highlights

James is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves leveraging his expertise in biotechnology to advance research and development efforts within the organization. His innovative approach has contributed to the company's mission of improving health outcomes.

Collaborations

James has collaborated with notable colleagues, including Ivan G Otterness and Peter S Mezes. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in their field.

Conclusion

James T Downs exemplifies the spirit of innovation in biotechnology through his patent and work at Pfizer Corporation. His contributions are vital to advancing our understanding of protein fragments and their implications in biological research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…